Cargando…

Comorbidities and Malignancy among NAFLD Patients Compared to the General Population, A Nation-Based Study

(1) Background: Non-alcoholic fatty liver disease (NAFLD) is a common liver disease. Aims: We aimed to investigate the frequency of comorbidities and malignancies among NAFLD patients compared to the general population. (2) Methods: A retrospective study included adult patients with a NAFLD diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abu-Freha, Naim, Cohen, Bracha, Gordon, Michal, Weissmann, Sarah, Fich, Alexander, Munteanu, Daniela, Yardeni, David, Etzion, Ohad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136025/ https://www.ncbi.nlm.nih.gov/pubmed/37189727 http://dx.doi.org/10.3390/biomedicines11041110

Ejemplares similares

Comorbidities and Outcomes among Females with Non-Alcoholic Fatty Liver Disease Compared to Males
por: Abu-Freha, Naim, et al.
Publicado: (2022)

Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents
por: Abu-Freha, Naim, et al.
Publicado: (2023)

Colorectal cancer among inflammatory bowel disease patients: risk factors and prevalence compared to the general population
por: Abu-Freha, Naim, et al.
Publicado: (2023)

Comorbidities and Risk Factors of Patients Diagnosed with CRC after Positive Fecal Test in Real Life
por: Abu-Freha, Naim, et al.
Publicado: (2022)

ASCA and ANCA among Bedouin Arabs with inflammatory bowel disease, the frequency and phenotype correlation
por: Abu-Freha, Naim, et al.
Publicado: (2018)

Adherence to Anti-Viral Treatment for Chronic Hepatitis B
por: Abu-Freha, Naim, et al.
Publicado: (2020)

Indications and Findings of Upper Endoscopies in Males and Females, Are They the Same or Different?
por: Abu-Freha, Naim, et al.
Publicado: (2021)

Spontaneous Bacterial Peritonitis among Cirrhotic Patients: Prevalence, Clinical Characteristics, and Outcomes
por: Abu-Freha, Naim, et al.
Publicado: (2021)

Chronic hepatitis C: Diagnosis and treatment made easy
por: Abu-Freha, Naim, et al.
Publicado: (2022)

NAFLD or comorbidities, that is the question
por: Ponziani, Francesca Romana, et al.
Publicado: (2020)

Comorbidities and Metabolic Derangement of NAFLD
por: Bang, Ki Bae, et al.
Publicado: (2015)

Reply to: ‘NAFLD or comorbidities, that is the question’
por: Ji, Dong, et al.
Publicado: (2020)

Efficacy and safety of sequential versus quadruple therapy as second-line treatment for helicobacter pylori infection—A randomized controlled trial
por: Munteanu, Daniela, et al.
Publicado: (2017)

The impact of the COVID-19 pandemic on colorectal and gastric cancer diagnosis, disease stage and mortality
por: Abu-Freha, Naim, et al.
Publicado: (2022)

Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts
por: Lamprecht, Sergio, et al.
Publicado: (2018)

Current Management of NAFLD
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2016)

Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study
por: Etzion, Ohad, et al.
Publicado: (2020)

Hepatitis C Elimination: Opportunities and Challenges in 2023
por: Taha, Gadeer, et al.
Publicado: (2023)

Maternal Hepatitis B Virus or Hepatitis C Virus Carrier Status and Long-Term Endocrine Morbidity of the Offspring—A Population-Based Cohort Study
por: Abu Freha, Naim, et al.
Publicado: (2020)

From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome?
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2014)

Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD
por: Linge, Jennifer, et al.
Publicado: (2020)

NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
por: Michelotti, Anna, et al.
Publicado: (2021)

Ethnic Issues and Disparities in Inflammatory Bowel Diseases: What Can We Learn from the Arab Population in Israel?
por: Abu-Freha, Naim, et al.
Publicado: (2023)

NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome
por: Rosato, Valerio, et al.
Publicado: (2019)

COVID-19 Vaccination Among the Arab Bedouin Population: Lessons Learned From a Minority Population
por: Abu-Freha, Naim, et al.
Publicado: (2022)

Higher Overall Intakes Are the Defining Feature of Dietary Intakes in NAFLD and Compared to the General Population
por: Properzi, Catherine, et al.
Publicado: (2023)

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

Coping strategies, satisfaction with life, and quality of life in Crohn’s disease: A gender perspective using structural equation modeling analysis
por: Sarid, O., et al.
Publicado: (2017)

Aging, Inflammation, and Comorbidity in Cancers—A General In Silico Study Exemplified by Myeloproliferative Malignancies
por: Ottesen, Johnny T., et al.
Publicado: (2023)

A multistakeholder approach to innovations in NAFLD care
por: Schattenberg, Jörn M., et al.
Publicado: (2023)

The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease
por: Alkhouri, Naim, et al.
Publicado: (2014)

Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017–2018 transient elastography data and application of machine learning
por: Noureddin, Mazen, et al.
Publicado: (2022)

Dual Role of MicroRNAs in NAFLD
por: Ceccarelli, Sara, et al.
Publicado: (2013)

NAFLD in the Elderly
por: Alqahtani, Saleh A, et al.
Publicado: (2021)

Neuromuscular Scoliosis: Comorbidities and Complications
por: Weissmann, Karen Andrea, et al.
Publicado: (2021)

Post‐polypectomy surveillance colonoscopy: Comparison of the updated guidelines
por: Abu‐Freha, Naim, et al.
Publicado: (2021)

Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes
por: Abu-Farha, Mohamed, et al.
Publicado: (2022)

Identification of 90 NAFLD GWAS loci and establishment of NAFLD PRS and causal role of NAFLD in coronary artery disease
por: Miao, Zong, et al.
Publicado: (2021)

TSH Levels as an Independent Risk Factor for NAFLD and Liver Fibrosis in the General Population
por: Martínez-Escudé, Alba, et al.
Publicado: (2021)

Safety and Efficacy of Combined Low-Dose Lithium and Low-Dose Aspirin: A Pharmacological and Behavioral Proof-of-Concept Study in Rats
por: Shvartsur, Rachel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lkcl5gk2u8j6nfui6kscccn55s